FGF19 upregulates ELF4 expression via the ERK1/2-SP1 axis, which subsequently activates downstream targets like SRC and FGFR4 itself, creating a positive feedback loop that amplifies the metastatic potential of CRC cells [198]. The gene discussed is FGFR4; the disease is colorectal carcinoma.